Skip Nav Destination
            
    
            
 
    
    
        
            
                
                    
                        
                        
                            
                        
                    
                
                    
                    
                        
                    
                
                
                    
                        
                        
                            
                        
                    
            
        
    
    
    
    
        
            
        
        
    
        
    
    
    
 
    
                
                    
            
    
        
    
    
                    
        
        
     
    
                     
    
                     
    
                    
        
                    
        
        Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                    
        
                    
        
        Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                    
        
                    
        
        Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                    
                    
                
            
    
    
    
        
        
     
    
                    
        
        
     
    
 
    
            
    
        
    
         
 
    
    
        
    
            
    
        
    
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
        
    
    
    
            
        
 
    
    
 
    
    
         
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
 
    
    
    
    
        
    Issue Archive
Table of Contents
BLOOD COMMENTARIES
BLOOD SPOTLIGHT
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
        
        Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Kerry A. Rogers,Ying Huang,Amy S. Ruppert,Farrukh T. Awan,Nyla A. Heerema,Corinne Hoffman,Gerard Lozanski,Kami J. Maddocks,Mollie E. Moran,Mark A. Reid,Margaret Lucas,Jennifer A. Woyach,W. Thomas Whitlow,Jeffrey A. Jones,John C. Byrd
            
        
    
            LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
        
        Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Sanne Noort,Martin Zimmermann,Dirk Reinhardt,Wendy Cuccuini,Martina Pigazzi,Jenny Smith,Rhonda E. Ries,Todd A. Alonzo,Betsy Hirsch,Daisuke Tomizawa,Franco Locatelli,Tanja A. Gruber,Susana Raimondi,Edwin Sonneveld,Daniel K. Cheuk,Michael Dworzak,Jan Stary,Jonas Abrahamsson,Nira Arad-Cohen,Malgorzata Czogala,Barbara De Moerloose,Henrik Hasle,Soheil Meshinchi,Marry van den Heuvel-Eibrink,C. Michel Zwaan
            
        
    
            THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
        
        Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            TaeHyung Kim,Joon Ho Moon,Jae-Sook Ahn,Yeo-Kyeoung Kim,Seung-Shin Lee,Seo-Yeon Ahn,Sung-Hoon Jung,Deok-Hwan Yang,Je-Jung Lee,Seung Hyun Choi,Ja-yeon Lee,Marc S. Tyndel,Myung-Geun Shin,Yoo Jin Lee,Sang Kyun Sohn,Seong-Kyu Park,Zhaolei Zhang,Hyeoung-Joon Kim,Dennis Dong Hwan Kim
            
        
    
            LETTERS TO BLOOD
IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia
            Ameera Alsadeq,Lennart Lenk,Anila Vadakumchery,Antony Cousins,Christian Vokuhl,Ahmad Khadour,Fotini Vogiatzi,Felix Seyfried,Lueder-Hinrich Meyer,Gunnar Cario,Elias Hobeika,Klaus-Michael Debatin,Christina Halsey,Martin Schrappe,Denis M. Schewe,Hassan Jumaa
            
        
    
            BLOOD WORK
- 
        
            Cover Image
        
        Cover Image![issue cover]()  Safranin O–fast green–hematoxylin-stained knee joint from an injured FVIII−/− mouse, showing extravasated and pooled erythrocytes (dark green), resulting in inflammation and joint swelling. This model was used to uncover that defective thrombin-activatable fibrinolysis inhibitor (TAFI) activation contributes to hemophilic joint bleeding. See the article by Wyseure et al on page 1593. 
- PDF Icon Front MatterFront Matter
- PDF Icon Table of ContentsTable of Contents
- PDF Icon Back MatterBack Matter
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
 
                    





